Santhera Pharmaceuticals Holding AG

    Jurisdiction
    Switzerland
    LEI
    54930035HAOFTTQH0U85
    ISIN
    CH1276028821 (SANN.SW)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. Read full profile

    Fundamentals

    Net revenue
    €152.51M
    Gross margin
    86.1%
    EBIT
    €18.38M
    EBIT margin
    12.1%
    Net income
    €13.71M
    Net margin
    9.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €75.78M -50.3% -€34.88M -354.5%
    €103.45M +36.5% €2.50M -107.2%
    €122.98M +18.9% €5.67M +126.5%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications